Sensei Biotherapeutics (SNSE) Institutional Ownership $10.81 -0.39 (-3.48%) Closing price 04:00 PM EasternExtended Trading$10.64 -0.17 (-1.57%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sensei Biotherapeutics (NASDAQ:SNSE)CurrentInstitutional OwnershipPercentage10.50%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$905.55KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$576.08K Get SNSE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data SNSE Institutional Buying and Selling by Quarter Sensei Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025XTX Topco Ltd62,903$31K0.0%+351.7%0.250% 2/13/2025Renaissance Technologies LLC156,800$77K0.0%-27.3%0.623% 11/15/2024National Bank of Canada FI45,575$27K0.0%+355.8%0.181% 11/14/2023Newtyn Management LLC1,800,000$1.35M0.3%-1.5%7.200% 11/14/2022RA Capital Management L.P.683,529$1.06M0.0%-5.5%2.225% 7/22/2022Truist Financial Corp19,934$45K0.0%-60.5%0.065% 5/3/2022Leo Brokerage LLC14,845$34K0.0%N/A0.048% 11/16/2021Millennium Management LLC258,659$2.72M0.0%N/A0.846% 11/16/2021Moore Capital Management LP49,341$519K0.0%-61.3%0.161% 11/12/2021Tao Capital Management LP32,784$345K0.1%N/A0.107% Get the Latest News and Ratings for SNSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sensei Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021The Manufacturers Life Insurance Company13,478$142K0.0%N/A0.044% 11/12/2021Geode Capital Management LLC273,978$2.88M0.0%+93.2%0.896% 11/10/2021Citigroup Inc.2,409$25K0.0%+565.5%0.008% 11/9/2021BlackRock Inc.1,000,322$10.52M0.0%+175.2%3.270% 11/5/2021Truist Financial Corp70,374$740K0.0%N/A0.230% 11/4/2021Deutsche Bank AG12,021$126K0.0%+158.3%0.039% 11/1/2021SG Americas Securities LLC12,614$133K0.0%N/A0.041% 10/13/2021BFT Financial Group LLC14,845$156K0.0%N/A0.049% 8/17/2021Citadel Advisors LLC283,667$2.77M0.0%-59.0%0.927% 8/16/2021Alyeska Investment Group L.P.40,000$390K0.0%N/A0.131% 8/16/2021Tudor Investment Corp Et Al28,111$274K0.0%-75.2%0.092% 8/16/2021Charles Schwab Investment Management Inc.54,965$537K0.0%+18.9%0.180% 8/16/2021State Street Corp100,000$976K0.0%+70.2%0.327% 8/13/2021Northern Trust Corp75,011$733K0.0%-8.5%0.245% 8/13/2021Geode Capital Management LLC141,809$1.38M0.0%+20.8%0.464% 8/13/2021Vanguard Group Inc.387,753$3.78M0.0%+19.4%1.268% 8/12/2021JPMorgan Chase & Co.179,078$1.75M0.0%+15.1%0.585% 8/11/2021Bank of New York Mellon Corp18,431$180K0.0%+31.1%0.060% 8/11/2021BlackRock Inc.363,466$3.55M0.0%+9.2%1.188% 8/11/2021Deutsche Bank AG4,653$45K0.0%-73.3%0.015% (Data available from 1/1/2016 forward) SNSE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNSE shares? During the previous two years, the following institutional investors and hedge funds held shares of Sensei Biotherapeutics shares: Newtyn Management LLC ($1.35M), Renaissance Technologies LLC ($77K), and XTX Topco Ltd ($31K), National Bank of Canada FI ($27K).Learn more on Sensei Biotherapeutics' institutional investors. What percentage of Sensei Biotherapeutics' stock is owned by institutional investors? 10.50% of Sensei Biotherapeutics' stock is owned by institutional investors. Learn more on SNSE's institutional investor holdings. Which institutional investors have been buying Sensei Biotherapeutics' stock? The following institutional investors have purchased Sensei Biotherapeutics' stock in the last 24 months: XTX Topco Ltd ($48.98K), and National Bank of Canada FI ($35.58K). How much institutional buying is happening at Sensei Biotherapeutics? Institutional investors have bought a total of 84,552 shares in the last 24 months. This purchase volume represents approximately $905.55K in transactions. Which of Sensei Biotherapeutics' major shareholders have been selling company stock? The following institutional investors have sold Sensei Biotherapeutics stock in the last 24 months: Renaissance Technologies LLC ($58.77K). How much institutional selling is happening at Sensei Biotherapeutics? Institutional investors have sold a total of 58,772 shares in the last 24 months. This volume of shares sold represents approximately $576.08K in transactions. Related Companies OTLK Major Shareholders GNTA Major Shareholders ELYM Major Shareholders ACRV Major Shareholders SNTI Major Shareholders ICCC Major Shareholders AADI Major Shareholders BRNS Major Shareholders QNTM Major Shareholders ADAP Major Shareholders This page (NASDAQ:SNSE) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredBitcoin is dead?Bitcoin’s historic run may be ending — and Weiss Ratings’ Juan Villaverde, who’s nailed every major crypto bul...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
